Predictive testing can be used to assess the risk of various types of cancer, including breast cancer, ovarian cancer, colorectal cancer, and prostate cancer. For example, mutations in the BRCA1 and BRCA2 genes are known to increase the risk of both breast and ovarian cancer.
